Results

Veru Inc.

06/25/2021 | Press release | Distributed by Public on 06/25/2021 06:39

Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111) in Metastatic Castration Resistant and Androgen Receptor Targeting Agent Resistant[...]